Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.82 USD | +0.66% | -0.66% | +23.51% |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 8.89B |
---|---|---|---|---|---|
Net income 2024 * | 227M | Net income 2025 * | 382M | EV / Sales 2024 * | 3.49 x |
Net cash position 2024 * | 262M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 3.07 x |
P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
23.6
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.75% |
Latest transcript on Globus Medical, Inc.
1 day | +0.66% | ||
1 week | -0.66% | ||
Current month | +32.20% | ||
1 month | +30.21% | ||
3 months | +16.64% | ||
6 months | +42.87% | ||
Current year | +23.51% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | 0.00% | ||
0.99% | 144 M€ | +1.42% | - | |
0.74% | 14 M€ | -4.84% | ||
0.44% | 8 M€ | +4.90% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 65.82 | +0.66% | 636,464 |
24-05-23 | 65.39 | -2.62% | 627,365 |
24-05-22 | 67.15 | +0.98% | 959,877 |
24-05-21 | 66.5 | +0.36% | 870,799 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.51% | 8.89B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- GMED Stock